Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Achillion
Achillion
Lessons From The Liver Meeting: Sagient's John Tucker Names Companies That Could Reignite The Hepatitis C Industry
Seeking Alpha
Fri, 11/30/12 - 12:10 pm
hepatitis C
Achillion
Gilead
Idenix
Merck
Medivir
Vertex Pharmaceuticals
5 Drug Hopefuls That Are Going to Change Your Life: Part 2
Motley Fool
Sat, 11/24/12 - 12:01 pm
Gilead Sciences
sofosbuvir
hepatitis C
Bristol-Myers Squibb
BMS-986094
Idenix
IDX-184
Abbott Laboratories
Achillion
ACH-3102
Has Achillion Pharmaceuticals Become the Perfect Stock?
Motley Fool
Sat, 11/24/12 - 11:39 am
Achillion
This Week in Biotech: Part 1 (The Hep-C Chronicles)
Motley Fool
Sat, 11/17/12 - 01:47 pm
Gilead Sciences
Abbott Laboratories
Idenix
Achillion
hepatitis C
Does Achillion Have a Place in the HCV Market of the Future?
Yahoo/Reuters
Wed, 11/14/12 - 12:30 pm
Achillion
hepatitis C
Abbott Labs
Gilead
ACH-1625
Vertex Pharmaceuticals
3 Reasons Why Not All Hep C Data Is Created Equal
Motley Fool
Tue, 11/13/12 - 11:51 am
hepatitis C
Gilead
Abbott Labs
Vertex Pharmaceuticals
Achillion
Idenix
Buyout Buzz: The most frequently cited takeover targets in biotech
Fierce Biotech
Tue, 11/6/12 - 04:32 pm
biotech
M&A
Amarin
Achillion
ONYX Pharmaceuticals
Actelion
Elan
Forest Labs
Medivation
Biomarin
Indenix
For Hep C Investors, What Goes Around Comes Around
Motley Fool
Sat, 11/3/12 - 11:28 am
hepatitis C
Vertex Pharmaceuticals
Gilead Sciences
Abbott Laboratories
Idenix
Achillion
BioCryst, Presidio Merger Creates Yet Another Competitor in the HCV Segment
Yahoo/Fly on the Wall
Thu, 10/18/12 - 01:10 pm
Biocryst
Presidio
hepatitis C
M&A
Gilead
Abbott Labs
Achillion
[video] The Next Big Thing in Biotech: Hepatitis Drugs
TheStreet.com
Fri, 09/28/12 - 10:18 am
hepatitis C
Abbott Labs
Gilead Sciences
JNJ
Merck
Vertex Pharmaceuticals
Idenix
Achillion
Achillion Announces Positive Proof-of-Concept Data With ACH-3102
Yahoo
Thu, 09/27/12 - 10:51 am
ACH-3102
Achillion
Achillion Pharma draws bullish bet
Yahoo/optionMONSTER
Tue, 09/25/12 - 04:01 pm
Achillion
Achillion Back On The Hep C Roller Coaster Of Love
Seeking Alpha
Wed, 09/19/12 - 11:30 am
Achillion
hepatitis C
Abbott Labs
Gilead
JNJ
Merck
Pfizer
ACH-1625
7 Rallying Biotech Stocks Being Snapped Up By Hedge Funds
Seeking Alpha
Sat, 09/15/12 - 09:30 am
Achillion
Affymax
Alexion
Jazz Pharmaceuticals
ONYX Pharmaceuticals
Threshold Pharmaceuticals
ViroPharma
Achillion announces SVR4 of 85%-100% from trial evaluating sovaprevir
Yahoo/Fly on the Wall
Tue, 08/7/12 - 05:56 pm
Achillion
sovaprevir
hepatitis C
Insiders Bought 3 Plunging Healthcare Stocks Last Week, And 3 Other Noteworthy Buys And 5 Sells
Seeking Alpha
Sat, 06/16/12 - 01:54 pm
Achillion
Allscripts
Targacept
Endo
United Therapeutics
Nanosphere
Achillion jumps on hepatitis C study
Marketwatch
Mon, 05/21/12 - 04:49 pm
Achillion
hepatitis C
ACH-2684
Achillion's hepatitis C drug gets FDA fast track
Reuters
Tue, 05/15/12 - 12:11 pm
Achillion
hepatitis C
fast track
FDA
ACH-3102
5 Biotech Stocks That Could Soar On New Hepatitis C Drugs
Seeking Alpha
Sat, 04/21/12 - 12:17 pm
Vertex
Incivek
ABT-072
ABT-450
Abbott Laboratories
Achillion
ACH-1625
ACH-2684
ACH-2928
ACH-3102
TMC435
JNJ
GSK
hepatitis C
Achillion Announces 94 - 100% Complete EVR From Phase 2 Trial With ACH-1625 Based Regimen in Hepatitis C
Yahoo/Globe NewsWire
Sat, 04/21/12 - 12:05 pm
Achillion
ACH-1625
ACH-3102
ACH-2928
hepatitis C
Pages
« first
‹ previous
1
2
3
4
5
6
7
next ›
last »